Table 3.
Medication during hospitalization and hospitalization days
| Variable | Category | Jan, 2020 – Jun, 2021 (n = 46,336) | Jul, 2021 – Dec, 2022 (n = 26,246) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-asthma, COPD | Asthma | COPD | Asthma+COPD | Non-asthma, COPD | Asthma | COPD | Asthma+COPD | ||
| 42,819 | 2302 | 1087 | 128 | 23,905 | 1429 | 820 | 92 | ||
| Treatment (%) | Yes | 21,913 (51.2) | 1295 (56.3) | 775 (71.3) | 92 (71.9) | 15,393 (64.4) | 961 (67.2) | 644 (78.5) | 70 (76.1) |
| Remdesivir (%) | Yes | 7387 (17.3) | 455 (19.8) | 329 (30.3) | 37 (28.9) | 9292 (38.9) | 533 (37.3) | 402 (49.0) | 42 (45.7) |
| Tocilizumab (%) | Yes | 1272 (3.0) | 70 (3.0) | 53 (4.9) | 4 (3.1) | 634 (2.7) | 40 (2.8) | 21 (2.6) | 2 (2.2) |
| Corticosteroid (%) | Yes | 14,318 (33.4) | 893 (38.8) | 630 (58.0) | 74 (57.8) | 6817 (28.5) | 446 (31.2) | 294 (35.9) | 29 (31.5) |
| mPSL1000mg/day | 1076 (2.5) | 56 (2.4) | 55 (5.1) | 10 (7.8) | 547 (2.3) | 18 (1.3) | 28 (3.4) | 547 (2.3) | |
| mPSL1mg/kg/day | 1263 (2.9) | 67 (2.9) | 51 (4.7) | 10 (7.8) | 134 (0.6) | 6 (0.4) | 6 (0.7) | 134 (0.6) | |
| DEX6mg/day | 5532 (23.1) | 350 (24.5) | 232 (28.3) | 20 (21.7) | |||||
| Hospitalization days (mean SD) | 15.05 (19.40) | 14.17 (16.47) | 21.20 (23.34) | 23.54 (37.45) | 15.50 (28.00) | 12.58 (18.07) | 20.88 (28.65) | 17.72 (14.37) | |
COPD chronic obstructive pulmonary disease, mPSL methylprednisolone, DEX dexamethasone